SEC Form 4 · accession 0001127602-18-006010
LABCORP HOLDINGS INC. · LH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David P King
Officer — President & CEO · Director
Period of report
Feb 12, 2018
Accepted (ET)
Feb 14, 2018 · 2:34 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000920148
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitF3,F1,F2 | — | Feb 12, 2018 | A | 10,540 | A | — | — | Common Stock | 10,540 | 32,601 | D |
| Non-qualified Stock OptionsF4,F5 | $168.49 | Feb 12, 2018 | A | 41,000 | A | Feb 12, 2019 | Feb 11, 2028 | Common Stock | 41,000 | 41,000 | D |
Explanation of responses
- F1Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.
- F2The Restricted Stock Units vest in three equal annual installments beginning on 2/12/2019.
- F3This number reflects the aggregate number of Restricted Stock Units held by the reporting person.
- F4Employee stock option (right to buy) granted pursuant to the Laboratory Corporation of America Holdings 2016 Omnibus Incentive Plan.
- F5The option vests in three equal installments beginning on the date reflected in this column.